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Abstract 
We investigated whether sulfatides are able to trigger transmembrane signals and activation of selective cell functions in human monocytes. 
Sulfatides stimulated an increase in cytosolic free-calcium in monocytes, and this depended on the release of calcium from intracellular stores. 
Non-sulfated galactocerebrosides had no effect on monocyte cytosolic free calcium. Sulfatides enhanced expression of tumor necrosis factor, 
interleukin-8, and interleukin-lb, but not interleukin-12/natural killer cell stimulating factor mRNAs. Sulfatides also triggered secretion of cytokines 
into the extracellular medium, although they were much less effective than lypopolysaccharide. Both enhanced expression of cytokine mRNAs and 
secretion by sulfatides required sulfation of the galactose ring of the glycolipid as non-sulfated galactocerebrosides had no effect. These findings 
suggest that sulfatides that are released at sites of inflammation can amplify the inflammatory reaction triggering cytokine expression in, and release 
by, monocytes. 
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1. Introduction 
The effector and regulatory role of mononuclear 
phagocytes in inflammation is largely due to their capa- 
bility to secrete cytokines. Cytokine gene expression in, 
and secretion by, mononuclear phagocytes occurs upon 
interaction with a wide array of molecules present in the 
inflamed interstitium. Apart from cytokines themselves, 
identification of molecules released by tissues undergo- 
ing pathologic alterations, and potentially able to trigger 
directly cytokine expression, is still limited. 
In the course of investigations on the role of mononu- 
clear phagocytes in the effector phase, and amplification 
of demyelinating diseases it was shown that the myelin 
P2 protein triggers secretion of tumor necrosis factor, 
and other proinflammatory cytokines [l]. A major con- 
stituent of the myelin sheet are glycolipids, including 
sulfated, and non-sulfated galactocrebrosides [2]. The 
sulfated forms of galactocerebrosides ( ulfatides) have 
recently attracted the attention of different groups of 
investigators as ligands for members of the selectin fam- 
ily of adhesion molecules [3-61. Evidence has also been 
presented that sulfatides expressed on the plasma mem- 
brane of, and excreted by, both myeloid and tumor cells 
represent ligands for P-selectin [7]. Although the physio- 
logical significance of ligation of sulfatides by selectins 
is not known, we have started to address whether sulfat- 
ides can act as signalling molecules able to trigger selec- 
tive leukocyte functions. 
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We show in this paper that sulfatides, but not non- 
sulfated galactocerebrosides, are able to transduce sig- 
nals in human monocytes, and enhance cytokine gene 
expression and secretion. Our findings suggest hat sul- 
fatides released at sites of inflammation, as for example 
in the course of demyelinating diseases, can contribute 
to amplification and persistance of inflammatory reac- 
tions stimulating cytokine secretion by monocytes. 
2. Materials and methods 
2.1. Purification and cultivation of monocytes 
Peripheral blood mononuclear cells were obtained from blood buffy 
coats of healthy donors by centrifugation over a Ficoll-Hypaque gradi- 
ents. For purification of monocytes as a suspension of cells for the 
measurement of cytosolic free calcium, mononuclear cells were resus- 
pended at lO’/mI in RPM1 1640 medium supplemented with 2 mM 
glutamine, 10% foetal calf serum (FCS) and 4 mM HEPES, and previ- 
ously adjusted to an osmolarity of 285 mOsmol/l with distilled water 
(iso-osmotic medium). Monocyte suspensions were layared over 46% 
Percoll (Pharmacia Biotech Europe, Brussels, Belgium; adjusted to an 
osmolarity of 285 mOsmol/l with 10 x phosphate-buffered saline), and 
then centrifuged at 550 x g for 30 min at room temperature. Monocytes 
were collected at the interface between the iso-osmotic medium and the 
Percoll, washed in PBS, and suspended in Hank’s balanced salt solution 
supplemented with 0.5 mM CaCI, and 5.5 mM glucose (HCaG) at a 
density of 10 x IO6 cells/ml. Cytocentrifuge preparations of the mon- 
ocyte suspensions stained by May-Grunwald-Giemsa staining, or for 
non-specific esterase activity showed that these preparations consisted 
of more than 95% monocytes. 
For the measurement of cytokine expression, mononuclear cells col- 
lected from Ficoll-Hypaque gradients were washed in PBS, resus- 
pended in RPM1 1640 medium supplemented with 2 mM glutamine, 
and heat-inactivated 5% human serum, pooled from lo-15 healthy 
donors, and plated in 6-well tissue culture plates (Nunc, Roskilde, 
Denmark) at I5 x lO”/ml/well. After 1 h at 37°C non-adherent cells 
were removed by several washings with PBS, and the remaining adher- 
ent cells (between 95 and 98% positive for non-specific esterase stain- 
ing), were stimulated immediately, or after I day of culture at 37°C in 
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95% sir/5% CO*. Cell-free supernatants were harvested, spun at 
8000 x g and stored at -20°C. Adherent cells were extracted for total 
RNA. All the solutions used in these studies were prepared in lypo- 
polysaccharide-free water for clinical use. 
2.2. Monocyte stimulation 
Monocytes were stimulated with sulfatides (Sigma Diagnostics, St. 
Louis, MO, or Fluka Chemika-Biochemika, Buchs, Switzerland), ga- 
lactocerebrosides (Sigma), concanavalin A (Sigma), formyl-methionyl- 
leucyl-phenilalanine (Sigma), or lypopolysaccharide (LPS from E. coli, 
serotype 026.B6; Sigma). Sulfatides and galactocerebrosides were dis- 
solved in PBS at 5 mg/ml and sonicated for 3 min. 
2.3. Measurement of cytosolicfree calcium in humanpuriJed monocytes 
This was performed on suspensions of Fura-2/AM-loaded mon- 
ocytes. Loading of monocytes with Fura-2/AM, and measurement of 
cytosolic free calcium was exactly as described in [8]. 
2.4. RNA isolation and Northern blot analysis 
Total RNA was extracted and analysed as previously described [9]. 
Equal amounts of total RNA (10 pg) were loaded on each gel lane. 
mRNAs for TNF, IL-ID, IL-8 natural killer stimulating factor/IL-121 
p40 (NKSF/IL-12/p40) and actin were detected by hybridization of 
nylon filters (Schleicher and Schuell, Dassel, Denmark) with ‘*P-labeled 
cDNA fragments (Ready to go DNA labelling kit; Pharmacia Biotech 
Europe, Brussels, Belgium). Autoradiographs were quantitated by 
using a laser densitometer (LKB Instruments, TX), and the values were 
normalized with those of the uninduced cells on the basis of hybridiza- 
tion with actin probe. 
2.5. Cytokine assays 
Antigenic TNF was determined by using a double-ligand immunoas- 
say (50 pg/ml detection limit), developed in our laboratory [IO]. Ex- 
tracellular antigenic IL-8 was measured by a specific ELISA with a 
detection limit of 20 pg/ml [Ill. IL-I/3 was determined by a double- 
determinant RIA developed with Mab 609 and 206 (50 pg/ml detection 
limit) kindly donated by Dr. M.A. Cousin [l2]. IL-6 was determined 
with a specific ELISA kit purchased from BioSource International 
(Camarillo, CA, USA, detection limit of I5 pg/ml). NKSFIIL-I2 was 
determined by a double-determinant RIA detecting both the heterod- 
imer and the p40 free chain with a detection limit of IO pg/ml as 
described [I 31. 
2.6. Statistical analysis 
Data are expressed as means f S.E.M. The statistical evaluation of 
the data was performed by Student’s t-test for paired data and consid- 
ered significant if P < 0.05. 
3. Results and discussion 
3.1. Sulfatides trigger increase of cytosolic free calcium 
in human monocytes 
As shown in Fig. 1, sulfatides trigger an increase in 
cytosolic free calcium in monocytes. Sulfatides effect 
were detectable at 100 &ml, and increased up to 400 
@ml (panel A). Several observations indicate that this 
is not merely a consequence of alterations of plasma 
membrane permeability due to partition of these glycol- 
ipids in the membrane bilayer. Firstly, as shown in panel 
B, non-sulfated galactocerebrosides were uncapable of 
triggering an increase in cytosolic free calcium. Secondly, 
the response to sulfatides was modulated by agents 
which have been partially characterized as able to affect 
transmembrane signalling pathways activated by ag- 
onists of distinct surface receptors. In fact, depolimeriza- 
tion of filamentous actin by cytochalasin B enhanced 
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Fig. 1. Sulfatides trigger increase in cytosolic free calcium in monocytes. 
Monocytes were purified as described in section 2 and loaded with 
Fura-2IAM. 2 x lo6 cells in 2 ml of Hank’ s balanced salt solution 
supplemented with 0.5 mM CaCI,, and 5.5 mM glucose were stirred in 
the cuvette of a Perkin Elmer LS 50 Luminescence Spectrometer, and 
stimuli added at the point indicated by an arrow. In panel C, monocytes 
were pretreated for 3 min with 5 &ml cytochalasin B (CB) before 
addition of 4OO&ml sulfatides. In panel D, monocytes were pretreated 
for 3 min with 50 &ml phorbol myristate acetate (PMA) before addi- 
tion of 400 &ml sulaftides. Panel E shows the increase in cytosolic free 
calcium in response to 400 @ml sulaftides in the presence and in the 
absence of I mM EGTA. Representative r sults of experiments which 
were repeated 45 times are reported. 
(panel C) while pretreatment of the cell with PMA sup- 
pressed (panel D) the monocyte response to sulfatides. 
Cytochalasin B is known to potentiate signalling by chem- 
otactic agonists, and activation of protein kinase C by 
PMA inhibits receptor-mediated activation of phospho- 
lipase C by affecting G protein-phospholipase C cou- 
pling [14]. Finally, the increase in cytosolic free calcium 
depended on release from intracellular stores; in fact, 
chelation of extracellular calcium by 1 mM EGTA did 
not affect the response to sulfatides (panel E). 
Taken together, these findings point to the existence 
of a mechanism of action of sulfatides based on binding 
to distinct receptors. As sulfatides bind to L-selectin [3-61 
it is legitimate to speculate that, as we previously demon- 
strated in neutrophils [15], sulfatides’ effects might de- 
pend on ligation of L-selectin also in monocytes. 
3.2. Sulfatides augments the expression of cytokine 
mRNA in monocytes 
As shown in Fig. 2 exposure of monocytes to sulfatides 
for 6 h enhanced the expression of TNF, IL-lp, and IL-8 
mRNAs. At 6 h sulfatides enhanced expression of TNF, 
68 
6h 24h 
v) v) 
TNF 
IL- 1 a 
IL-8 
ACTI N 
Fig. 2. Sulfatides enhance expression of cytokine mRNAs in mon- 
ocytes. Monocytes were purified by adherence as described in section 
2 and cultivated for6 or 24 h, as indicated, in the presence of no stimulus 
(medium), LPS (10 &ml), or sulfatides (4OO&ml). Northern blots of 
total RNA (10 &lane) were hybridized with the indicated cDNA 
probes. Representative results of experiments which were repeated 
three times are reported. 
and IL-S at levels comparable to those found in mon- 
ocytes treated with 10 ng/ml of LPS, but they were less 
effective than LPS in enhancing IL-l/I mRNA expres- 
sion. After 24 h of treatment with sulfatides cytokine 
mRNAs expression decreased substantially (by 63, 50 
and 76% for TNF, IL-1B and IL-8, respectively, as re- 
vealed by densitometric analysis). Also when LPS was 
used as a stimulus, TNF mRNA expression decreased by 
about 60% after 24 h of treatment; however, expression 
of IL-lp and IL-8 did not change. The different kinetics 
of induction of IL-l/? and IL-8 mRNA expression by 
sulfatides and LPS indicates that the sulfatides effects did 
not depend on contamination with LPS. 
These findings show that sulfatides, which are simple 
constituents of the membrane of cells, which can be re- 
leased in the course of tissue injury can trigger cytokine 
mRNA expression and, in particular, of TNF and IL-8. 
These two cytokines play a central role in recruitment of 
inflammatory cell, and alterations of the endothelium 
involved in leukocyte adhesion and transmigration. The 
only stimuli which were previously shown to induce IL-8 
mRNA in monocytes are LPS, cytokines, and particles 
opsonised with IgG [ 11,161 
3.3. Production of cytokines by monocytes stimulated 
with sulfatides 
Sulfatides also trigger release of cytokines in the ex- 
tracellular medium (Fig. 3). After both 6 and 24 h of 
incubation with sulfatides we detected a significant in- 
crease in TNF, IL-l/?, IL-8, as well as IL-6, in the ex- 
G. Constantin et al. IFEBS Letters 350 (1994) 66-70 
tracellular medium. At 6 h, cytokine secretion in re- 
sponse to sulfatides was much lower than in response to 
LPS. In fact, LPS-induced secretion was 7-, 30-, 3- and 
200-fold higher than sulfatide-induced secretion for 
TNF, IL-lb, IL-8 and IL-6, respectively. Cytokine secre- 
tion after 24 h of challenge was also much higher in 
response to LPS than to sulfatides. Significantly, LPS, 
but not sulfatides, stimulated a high level of secretion of 
IL-12/NKSF, thus excluding the possibility that the de- 
scribed effect of sulfatides was due to contamination 
with LPS. 
The capability of sulfatides to trigger cytokine release 
was dose-dependent (not shown). A significant increase 
(P < 0.05, n = 3) of cytokine secretion was detected at 
100 pug/ml sulfatides with TNF, and IL-lp, at 400 ,&ml 
with IL-6, and at 10 &ml with IL-8. Also induction of 
TNF, and IL-8 mRNAs by sulfatides was dose-depend- 
ent (not shown). Independent of the concentrations used, 
sulfatides did not trigger any significant release of IL- 12/ 
NKSF, while, in accord with previous results [l, 131, LPS 
induced this cylokine. 
In order to obtain further evidence that the sulfatides’ 
effects were not due to contaminating LPS, we exploited 
the findings that at 100 pg/ml sulfatides also triggered 
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Fig. 3. Sulfatides trigger cytokine secretion by monocytes. Monocytes 
were purified by adherence as described in section 2 and cultivated for 
6 or 24 h, as indicated, in the presence of no stimulus (Medium), LPS 
(10 &ml), or sulfatides (400 pg/ml). Cell-free supernatants were pre- 
pared and analysed for the presence of cytokines as described in section 
2. The figure shows the means f S.E.M. of duplicate assays performed 
with supernatants collected and pooled from three wells for each condi- 
tion, Data derived from six experiments for TNF, IL-8 and IL-6, and 
seven for IL-la. *Indicates a P value (0.05) of statistically significant 
difference between sulfatide-treated and untreated cells. 
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Fig. 4. Insensitivity of sulfatide effects to polymixin B. Monocytes were purified by adherence as described in section 2 and cultivated for 6 h in the 
presence of no stimulus (Medium), 10 @ml LPS, or 100 &ml sulfatides in the absence or presence of 10 puglrnl polymixin B. Cell-free supernatants 
were prepared and analysed for the presence of cytokines as described in section 2. Mean results of triplicate assays f SD. of one representative 
of three experiments is reported. 
secretion of IL-la and IL-8. As reported in Fig. 4, inhi- 
bition of LPS-stimulated IL-l/I or IL-8 secretion by 
polymixin B, which prevents LPS’ biological activities 
[17], was by 97, and 84%, respectively, but inhibition of 
sulfatide-stimulated IL-la or IL-8 secretion by 
polymixin B was by 12 and 19% respectively. 
Comparing the effect of LPS, and sulfatides on cytokine 
mRNA expression and secretion it emerges that sulfatides 
are more effective in triggering signals involved in 
mRNA accumulation than in mRNA translation and/ or 
protein secretion. These findings suggest hat the main 
action of sulfatides is to prime monocytes, activating 
mechanisms leading to enhanced expression of cytokine 
mRNAs. Other factors present in the inflammatory site can 
synergise with sulfatides in triggering effective translation 
and secretion of cytokines in the extracellular milieau. 
A 
3.4. Sulfatide effects depend on the sulJbtion of the 
galactose ring 
The ability of sulfatides to enhance cytokine mRNA 
expression and secretion was strictly dependent on sul- 
fation of the glycolipid galactose ring. As shown in Fig. 
5, sulfatides reproducibly acted as stimuli of cytokine 
mRNA expression and secretion. However, treatement 
for 6 h (Fig. 5) or 24 h (not shown) with non-sulfated 
galactocerebrosides, at doses which were maximally 
stimulatory for sulfatides, caused neither secretion nor 
mRNA expression of TNF and IL-8. The data reported 
in Fig. 5A, relative to the expression of IL-12/NKSF, 
also strenghtens the conclusion, inferred from findings 
described above, that LPS possibly contaminating the 
sulfatides preparations we used does not contribute to 
the findings described in this paper. In fact, LPS, but not 
B 
Fig. 5. Dependence of sulfatides effects on sulfation of the galactose ring of galactocerebrosides. Monocytes were purified by adherence as described 
in section 2 and cultivated for 6 h in the presence of no stimulus (Medium), IO @ml LPS, or 400 &ml sulfatides, or galactocerebrosides (GalCer). 
(A) Cytokine mRNA expression. Northern blots of total RNA (IO&lane) were hybridized with the indicated cDNA probes. (B) Cytokine secretion. 
Cell-free supematants were prepared and analysed for the presence of cytokines as described in section 2. Representative r sults of one experiment 
which was repeated three times are reported. 
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sulfatides, acted as a powerful inducer of IL-121NKSF 
mRNA. 
Sulfatides are simple constitutents of the cell mem- 
brane. The human myelin contains as much as 3.8%, in 
dry weight, of sulfatides [2]. Sulfatides were shown to be 
released by neutrophils and tumor cells [7]. The physio- 
logical, or pathological significance of triggering of mon- 
ocyte functions by sulfatides remains to be elucidated. 
However, it is significant hat monocytes are thought to 
play a central role in inflammatory damage in the course 
of demyelinating diseases [ 18,191. Significantly, TNF has 
been shown to mediate myelin and olygodendrocyte 
damage in vitro [20,21], and to induce VCAM-1 and 
ICAM- on human neural cells [22]. It was also demon- 
strated that serum and cerebrospinal fluid of patients 
with actively progressive multiple sclerosis [23-251 and 
those with Guillain-Barre syndrome [23] contains in- 
creased concentrations of TNF and IL-l/?. Modulation 
of TNF and IL-8 expression by sulfatides can therefore 
amplify damage at the central nervous system and re- 
cruitment of inflammatory cells. 
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